New Onset Diabetes After COVID 19 (NODAC) is predominantly due to exacerbated Insulin Resistance (IR) rather than beta cell dysfunction: Lessons from tertiary care hospital data during confluence of two epidemics.
Juhi JamwalAnkit ChhabraAjaz QadirMohammad Ashraf GanieSyed Mudasir QadriAdnan LoneNaveed Nazir ShahPublished in: Endocrine (2024)
Preexisting DM is a risk factor for severe COVID 19 disease. Patients with NODAC have evidence of persistence insulin resistance on follow up, underscoring the need for long term glycemic monitoring.
Keyphrases
- insulin resistance
- type diabetes
- glycemic control
- coronavirus disease
- sars cov
- tertiary care
- adipose tissue
- high fat diet
- metabolic syndrome
- polycystic ovary syndrome
- skeletal muscle
- high fat diet induced
- cardiovascular disease
- healthcare
- single cell
- early onset
- electronic health record
- respiratory syndrome coronavirus
- cell therapy
- big data
- adverse drug
- acute care
- emergency department
- machine learning
- deep learning
- drug induced
- weight loss